Nancy Ryerson

Nancy Ryerson is a digital communicator with years of experience covering healthcare. Today, she's a Digital Marketing Manager at Antidote, where she manages the company's content marketing and SEO strategies. Prior to joining Antidote, Nancy spent three years at The Michael J. Fox Foundation, where she created content for Parkinson's disease patients and expanded the Foundation's email list by 100,000+ members in two years through search and social strategies. She holds a BA in English and journalism from NYU.

Find me on:

Nature: An AI boost for clinical trials

The Medical Futurist: "Top Companies Using A.I. In Drug Discovery And Development"

Topics: press

Startups.co.uk: "Clinical trial matching platform Antidote raises $11m"

MedCity News: "Three approaches to enhancing clinical trial recruitment"

PharmaPhorum: "Merck funds Antidote’s clinical trial matching tech"

MobiHealthNews: "Antidote Technologies raises $11M to speed development of trial matching platform"

CNBC: "Merck just plowed millions into this start-up to help get drugs to market faster"

MM&M: "Can marketing techniques save clinical trials?"

Fierce Biotech: "Clinical trial matching platform raises $11M backed by Merck’s tech fund"

Global Corporate Venturing: "Merck Puts Money into Antidote"